Eunjung Lee

Eunjung Lee

Auto-generated profile, based on publicly available information

Eunjung Lee

Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2020 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
SLSeungjae Lee
Seungjae Lee
TKTark Kim
Tark Kim
ELEunjung Lee
Eunjung Lee
CLCheolgu Lee
Cheolgu Lee
HKHojung Kim
Hojung Kim
TKTae Hyong Kim
Tae Hyong Kim
Since the first cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection were detected in Wuhan, China, in December 2019,1 a total of 4 789 205 laboratory-confirmed cases and 318 789 deaths have been documented globally as of May 20, 2020.2 An explosive outbreak among a religious group in Daegu, Republic of Korea (ROK), in February 2020 led to a vigorous containment strategy, including massive testing and active contact tracing. As the number of cases surpassed the capacity of the health care system, the Ministry of Health and Welfare of Korea decided to isolate asymptomatic and pauci-symptomatic patients in community treatment centers (CTCs),3 temporary facilities. The potential for transmission from asymptomatic people has been cited as an important factor in controlling the spread of novel coronavirus disease 2019 (COVID-19),4 but there is limited information about the clinical course and viral loads of asymptomatic people with SARS-CoV-2 infection. Using an asymptomatic patient cohort in a CTC, we describe the clinical course of asymptomatic infection and quantitatively compare the molecular viral load of SARS-CoV-2 between asymptomatic and symptomatic patients.

21 July 2022 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
YKYoonjung Kim
Yoonjung Kim
SKSeong Eun Kim
Seong Eun Kim
TKTark Kim
Tark Kim
KYKi Wook Yun
Ki Wook Yun
SLSo Hee Lee
So Hee Lee
YCYong Pil Chong
Yong Pil Chong
Kim Y, et al. Infect Chemother. 2022 Jul;54:e70. https://doi.org/10.3947/ic.2022.0141

1 January 2024 in Infection & Chemotherapy
Verified
Journal Article
Open access
JSJun-Won Seo
Jun-Won Seo
SKSeong Eun Kim
Seong Eun Kim
YKYoonjung Kim
Yoonjung Kim
EKEun-Jung Kim
Eun-Jung Kim
TKTark Kim
Tark Kim
JSJoon Young Song
Joon Young Song
Seo JW, et al. Infect Chemother. 2024 Mar;56:e11. https://doi.org/10.3947/ic.2024.0024

1 January 2013 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
SPSe Yoon Park
Se Yoon Park
JCJin Woo Choo
Jin Woo Choo
SKSoon Ha Kwon
Soon Ha Kwon
SYShi Nae Yu
Shi Nae Yu
ELEun Jung Lee
Eun Jung Lee
MJMin Huok Jeon
Min Huok Jeon
Park SY, et al. Infect Chemother. 2013 Sep;45(3):325-330. http://dx.doi.org/10.3947/ic.2013.45.3.325

14 November 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
CKChung-Jong Kim
Chung-Jong Kim
HKHong Bin Kim
Hong Bin Kim
MOMyoung-Don Oh
Myoung-Don Oh
YKYunhee Kim
Yunhee Kim
AKArim Kim
Arim Kim
TGThe KIND Study group (Korea Infectious Diseases Study group)
The KIND Study group (Korea Infectious Diseases Study group)
We estimated the nationwide burden of nosocomial S. aureus bloodstream infection (SA-BSI), a major cause of nosocomial infection, in South Korea. To evaluate the nationwide incidence of nosocomial SA-BSI, cases of SA-BSI were prospectively collected from 22 hospitals with over 500 beds over 4?months. Data on patient-days were obtained from a national health insurance database containing the claims data for all healthcare facilities in South Korea. The additional cost of SA-BSI was estimated through a matched case?control study. The economic burden was calculated from the sum of the medical costs, the costs of caregiving and loss of productivity. Three hundred and thirty nine cases of nosocomial SA-BSI were included in the study: 254 cases of methicillin-resistant SA-BSI (MRSA-BSI) and 85 cases of methicillin-susceptible SA-BSI (MSSA-BSI). Death related to BSI occurred in 81 cases (31.9%) of MRSA-BSI and 12 cases (14.1%) of MSSA-BSI. The estimated incidence of nosocomial MRSA-BSI was 0.12/1,000 patient-days and that of nosocomial MSSA-BSI, 0.04/1,000 patient-days. The estimated annual cases of nosocomial BSI were 2,946 for MRSA and 986 for MSSA in South Korea. The additional economic burden per case of nosocomial SA-BSI was US $20,494 for MRSA-BSI and $6,914 for MSSA-BSI. Total additional annual cost of nosocomial SA-BSI was $67,192,559. In view of the burden of nosocomial SA-BSI, a national strategy for reducing nosocomial SA-BSI is urgently needed in South Korea.

1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
EJEun-Jeong Joo
Eun-Jeong Joo
JKJae-Hoon Ko
Jae-Hoon Ko
SKSeong Eun Kim
Seong Eun Kim
SKSeung ji Kang
Seung ji Kang
JBJi Hyeon Baek
Ji Hyeon Baek
KPKyong Ran Peck
Kyong Ran Peck
Joo EJ, et al. J Korean Med Sci. 2021 Mar;36(11):e83. https://doi.org/10.3346/jkms.2021.36.e83